ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "hyaluronate and osteoarthritis"

  • Abstract Number: 1198 • 2017 ACR/ARHP Annual Meeting

    Intra-Articular Hyaluronic Acid Delay to Total Knee Arthroplasty By Number of Injection Courses Received: Analysis of an Administrative Database

    Andrew Concoff1, Faizan Niazi2, Peter Shaw2 and Jeffrey Rosen3, 1Rheumatology, St. Jude Medical Center, Fullerton, CA, 2Ferring Pharmaceuticals Inc., Parsippany, NJ, 3Department of Orthopaedics & Rehabilitation, New York Presbyterian Queens; Department of Clinical Orthopaedic Surgery, Weill Medical College of Cornell University, New York, NY, New York, NY

    Background/Purpose: Total knee arthroplasty (TKA) is the standard surgical treatment for patients with osteoarthritis (OA) that no longer experience symptom relief from conservative or pharmacologic…
  • Abstract Number: 1199 • 2017 ACR/ARHP Annual Meeting

    Costs Associated with Osteoarthritis Care Using Intra-Articular Hyaluronic Acid: Analysis of an Administrative Database

    Andrew Concoff1, Faizan Niazi2, Peter Shaw2 and Jeffrey Rosen3, 1Rheumatology, St. Jude Medical Center, Fullerton, CA, 2Ferring Pharmaceuticals Inc., Parsippany, NJ, 3Department of Orthopaedics & Rehabilitation, New York Presbyterian Queens; Department of Clinical Orthopaedic Surgery, Weill Medical College of Cornell University, New York, NY, New York, NY

    Background/Purpose: Many treatment options are available for the management of knee osteoarthritis (OA). The need for non-operative management is motivated by the large costs associated…
  • Abstract Number: 315 • 2016 ACR/ARHP Annual Meeting

    Hip Inflammation MRI Scoring System (HIMRISS) to Predict Response to Hyaluronic Acid (HAnox-M-XL) Injection in Hip Osteoarthritis

    Nicolas Deseyne1, Damien Loeuille2, Thierry Conrozier3, Ulrich Weber4, Jacob Jaremko5, Henri Lellouche6, Bernard Maillet7, Joel Paschke8, Jonathan Epstein9 and Walter P. Maksymowych10, 1Department of Rheumatology, CHRU Vandoeuvre les Nancy,, Vandoeuvre, France, 2Rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, 3Department of Rheumatology, North Hospital Franche-Comté, Belfort, France, 4Department of Research, King Christian 10th Hospital for Rheumatic Diseases, Graasten, Denmark, 5Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, 6Department of Rheumatology, Lariboisière Hospital, Paris, France, Paris, France, 7Department of Rheumatology, Clinique Saint Odilon, Moulins, France, Moulins, France, 8CaRE Arthritis, Edmonton, AB, Canada, 9CEC-Inserm CIE6, Epidemiology and Clinical Evaluations Department, CHRU Vandoeuvre les Nancy, France, Vandoeuvre Les Nancy, France, 10Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose:  To assess predictors of response, according to hip MRI inflammatory scoring system (HIMRISS), in a sample of patients with hip osteoarthritis (OA) treated by…
  • Abstract Number: 310 • 2015 ACR/ARHP Annual Meeting

    Hyaluronic Acid Injections in Knee Osteoarthritis Patients Are Associated with Delay to Knee Arthroplasty

    Kevin Ong1, Allen Anderson2, Edmund Lau3, Faizan Niazi4, Anke Fierlinger4, Steven Kurtz1 and Roy Altman5, 1Exponent, Inc., Philadelphia, PA, 2Tennessee Orthopaedic Alliance, Powderly, KY, 3Exponent, Inc., Menlo Park, CA, 4Ferring Pharmaceuticals, Inc., Parsippany, NJ, 5David Geffen School of Medicine, UCLA, Los Angeles, CA

    Background/Purpose: Although only few nonoperative treatment options for knee osteoarthritis (OA) are available, there continues to be debate about the effectiveness of hyaluronic acid (HA)…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology